TJ has descided to become active

TJ descided the become active to raise awareness and funding for spinal cord injury research in America.
Check out Tory's Head in the Clouds blog.

Let me bounce this idea off you folks. Ask Geron how much money in the bank it would take start and finish the Phase I trial. Then have people like TJ, Roman Reed and few famous people, raise the money, put it in a trust account. When the goal is reach the trial can begin. You could have a teletheon and  raise the money quickly

Good luck in this rigged casino,

Kiley Thomas doubled down

Kiley Thomas Director at Geron bought 64,275 more shares at $1.56 on 11-22-2011, for a total of 300,000+.  He believes or more likely he knows the share price will increase soon, because "Chip" the new CEO is wheeling and dealing.
Any price increase will sell a few shares and sell a few covered calls.

Good luck in this rigged casino,

Alex Barkas died suddenly Monday he was on Geron board of directors

Alex Barkas, biotech venture capitalist with Prospect Venture Partners died suddenly on Monday at 64. The cause of death hasn't been determined. He served on the board of Geron.

Geron not adding to Mondays gains, volume flat, share price down 12 cents. No good news yet.


Good luck in this rigged casino,

Nice move up with volume Geron

Closed up 12% with volume over 3.5 million shares. Great. Lets see what happens Tuesday. If we get more volume with a move up then I think we will have good news very soon.

Good luck in this rigged casino,

GERON the future in bio-tech: CIRM President helping Geron sell stem cell busine...

GERON the future in bio-tech: CIRM President helping Geron sell stem cell busine...: The $3 billion California stem cell agency CIRM, its President Alan Trounson say it is in talks with at least three firms in an effert to sa...

CIRM President helping Geron sell stem cell business

The $3 billion California stem cell agency CIRM, its President Alan Trounson say it is in talks with at least three firms in an effert to salvage Geron's orphan stem cell business. This is great news, it needs to be done very soon, 2 or 3 months tops.

Rumor on Yahoo Message Board is 2nd patient has more than a toe wiggle.
Note Geron's share price is up and climbing on a down big day. Volume is up. I brought 500 shares before I new all this at $1.43. It was interesting because my order was for 1000 shares only 500 filled. I think something is in the works by the price rise on a very very bad day and the volume incease.

Good luck in this rigged casino,

Geron 5th Patient injected

The Stanford University School of Medicine and Santa Clara Valley Medical treated the fifth patient in the Geron Corp. sponsored trial of a human embryonic-stem-cell-derived treatment for spinal cord injury on Nov. 16th.
Humans may need longer than a year to show results. It was shown that primates require more time than rats to recuperate.
Phase I results for GRN1005, Geron found the peptide/paclitaxel conjugate to be generally well tolerated. Since paclitaxel itself is an approved product, this is good news. Geron plans to initate two Phase II clinical trials for GRN1005 soon [December 2011] with data to become available in the first half of 2013. With good results it will most likely be fast tracked.


ACTC is in two Phase 1/2 trials, which injects embryonic stem cells into the eye,  one for Stargardt's Macular Dystrophy and Dry Age Related Macular Degeneration. Interesting news, patients want their second eye injected. That's a very strong indication that they are experiencing improvement. The studies are notable because Catholic nuns are among the patients. That is wild.

I'm long Geron and ACTC.

Good luck is this rigged casino,